These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 18923250

  • 1. The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis.
    Feng QZ, Zhao YS, Abdelwahid E.
    Coron Artery Dis; 2008 Nov; 19(7):527-34. PubMed ID: 18923250
    [Abstract] [Full Text] [Related]

  • 2. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure.
    Li Y, Takemura G, Kosai K, Takahashi T, Okada H, Miyata S, Yuge K, Nagano S, Esaki M, Khai NC, Goto K, Mikami A, Maruyama R, Minatoguchi S, Fujiwara T, Fujiwara H.
    Circ Res; 2004 Sep 17; 95(6):627-36. PubMed ID: 15297380
    [Abstract] [Full Text] [Related]

  • 3. Cardiomyocyte death and renewal in the normal and diseased heart.
    Buja LM, Vela D.
    Cardiovasc Pathol; 2008 Sep 17; 17(6):349-74. PubMed ID: 18402842
    [Abstract] [Full Text] [Related]

  • 4. G-proteins in growth and apoptosis: lessons from the heart.
    Adams JW, Brown JH.
    Oncogene; 2001 Mar 26; 20(13):1626-34. PubMed ID: 11313910
    [Abstract] [Full Text] [Related]

  • 5. A role for caspase-1 in heart failure.
    Merkle S, Frantz S, Schön MP, Bauersachs J, Buitrago M, Frost RJ, Schmitteckert EM, Lohse MJ, Engelhardt S.
    Circ Res; 2007 Mar 16; 100(5):645-53. PubMed ID: 17303764
    [Abstract] [Full Text] [Related]

  • 6. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress.
    Donath S, Li P, Willenbockel C, Al-Saadi N, Gross V, Willnow T, Bader M, Martin U, Bauersachs J, Wollert KC, Dietz R, von Harsdorf R, German Heart Failure Network.
    Circulation; 2006 Mar 07; 113(9):1203-12. PubMed ID: 16505176
    [Abstract] [Full Text] [Related]

  • 7. Myocyte apoptosis in heart failure.
    van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ.
    Cardiovasc Res; 2005 Jul 01; 67(1):21-9. PubMed ID: 15896727
    [Abstract] [Full Text] [Related]

  • 8. [From myocardial hypertrophy to heart failure: role of the interstitium].
    Barsotti A, Dini FL, Nardini V, Di Muzio M, Gallina S, Di Napoli P, Calafiore AM, Trevi G.
    Cardiologia; 1993 Dec 01; 38(12 Suppl 1):67-77. PubMed ID: 8020050
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis in the failing human heart.
    Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P.
    N Engl J Med; 1997 Apr 17; 336(16):1131-41. PubMed ID: 9099657
    [Abstract] [Full Text] [Related]

  • 10. Role of apoptosis in remodeling after myocardial infarction.
    Takemura G, Fujiwara H.
    Pharmacol Ther; 2004 Oct 17; 104(1):1-16. PubMed ID: 15500905
    [Abstract] [Full Text] [Related]

  • 11. The role of autophagy in the heart.
    Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K.
    Cell Death Differ; 2009 Jan 17; 16(1):31-8. PubMed ID: 19008922
    [Abstract] [Full Text] [Related]

  • 12. Alternative splicing of the primary Fas transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium.
    Schumann H, Morawietz H, Hakim K, Zerkowski HR, Eschenhagen T, Holtz J, Darmer D.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):794-8. PubMed ID: 9367848
    [Abstract] [Full Text] [Related]

  • 13. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure.
    Oka T, Akazawa H, Naito AT, Komuro I.
    Circ Res; 2014 Jan 31; 114(3):565-71. PubMed ID: 24481846
    [Abstract] [Full Text] [Related]

  • 14. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH, Shi Y, Chen Y, Sun M, Sader S, Maekawa Y, Arab S, Dawood F, Chen M, De Couto G, Liu Y, Fukuoka M, Yang S, Da Shi M, Kirshenbaum LA, McCulloch CA, Liu P.
    Circ Res; 2009 Apr 10; 104(7):896-904. PubMed ID: 19246681
    [Abstract] [Full Text] [Related]

  • 15. Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy?
    Balakumar P, Singh AP, Ganti SS, Krishan P, Ramasamy S, Singh M.
    Basic Clin Pharmacol Toxicol; 2008 Jan 10; 102(1):5-9. PubMed ID: 17973902
    [Abstract] [Full Text] [Related]

  • 16. SMAD-proteins as a molecular switch from hypertrophy to apoptosis induction in adult ventricular cardiomyocytes.
    Heger J, Peters SC, Piper HM, Euler G.
    J Cell Physiol; 2009 Aug 10; 220(2):515-23. PubMed ID: 19415695
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The role of apoptosis in ishemic damage to the myocardium].
    Rybakova MG, Kuznetsova IA.
    Arkh Patol; 2005 Aug 10; 67(5):23-5. PubMed ID: 16323475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart?
    Porrello ER, Widdop RE, Delbridge LM.
    Clin Exp Pharmacol Physiol; 2008 Nov 10; 35(11):1358-64. PubMed ID: 18759854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.